Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Citigroup Inc. Acquires 62,985 Shares of Day One Biopharmaceuticals, Inc.
Connor Clark & Lunn Investment Management Ltd.’s holdings in NGM Biopharmaceuticals were worth $792,000 at the end of the most recent reporting period.
Day One Biopharmaceuticals ( had its price objective reduced by Wedbush from $39.00 to $35.00 in a note issued to investors on Tuesday, reports.
Day One Biopharmaceuticals' Q1 2023 reveals a cash position of $318.2 million, which is expected to fund operations into 2025.
Franklin Resources Inc. grew its position in Day One Biopharmaceuticals by 59.8% in the second quarter.
RegeneRx Biopharmaceuticals has a fifty-two week low of $0.01 and a fifty-two week high of $0.25.
Renaissance Technologies LLC grew its position in Navidea Biopharmaceuticals, Inc. () by 264.5% in the first quarter, according to the company in its most recent disclosure with the SEC.